v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash $ 40,908 $ 1,084
Other current assets 595 595
Total current assets 41,503 1,679
Intangible asset, net of amortization 150
Total Assets 41,503 1,829
Current liabilities:    
Accounts payable and accrued expenses 265,530 124,620
Accrued salary 348,800 601,154
Notes payable 33,000 20,000
Notes payable to related party 17,885 17,585
Advances due to related party 10,974 7,675
Convertible note payable net of discounts 34,065
Derivative liability 42,104
Total current liabilities 752,358 771,034
Total liabilities 752,358 771,034
Commitments and contingencies
Stockholders' Equity (Deficit)    
Preferred stock, $.001 par value, 10,000,000 shares authorized with 1 share designated as Series A Preferred and 1,500,000 shares designated as Series B Convertible Preferred none issued or outstanding
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 121,984,192 and 87,704,686 shares issued and outstanding, as of December 31, 2018 and 2017, respectively 121,984 87,704
Additional paid in capital 3,242,449 2,579,489
Deferred officer compensation (195,054) (391,010)
Accumulated (deficit) (3,880,234) (3,045,388)
Total stockholders' (deficit) (710,855) (769,205)
Total Liabilities and Stockholders' Equity (Deficit) $ 41,503 $ 1,829
v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenue $ 2,574 $ 3,793
Cost of revenue 49
Gross profit 2,574 3,744
Operating expenses:    
General and administrative 747,963 259,594
Depreciation and amortization 150 975
Total operating expenses 748,113 260,569
(Loss) from operations (745,539) (256,825)
Interest expense (124,358)
Change in derivative liability 35,051
Net (loss) before income taxes (834,846) (256,825)
Provision for income taxes
Net (loss) $ (834,846) $ (256,825)
Per share information - basic and fully diluted:    
Weighted average shares outstanding (in shares) 93,166,625 27,006,662
Net (loss) per share (in dollars per share) $ (0.01) $ (0.01)
v3.19.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flow from operating activities:    
Net loss $ (834,846) $ (256,825)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization 150 975
Stock based compensation 47,927 56,479
Amortization of deferred compensation 195,956 900
Director and officer compensation accruals 324,000 154,600
Financing related costs - convertible debt 97,178
Change in derivative liability (35,051)
Changes in operating assets and liabilities:    
Other current assets 345
Accounts payable 140,911 (6,088)
Net cash used in operations (63,775) (49,614)
Cash flow from financing activities:    
Proceeds from notes payable 15,000 20,000
Repayment of note payable (2,000)
Proceeds from convertible debt 32,000
Proceeds from sale of common stock 55,000  
Proceeds from related party notes and advances 3,599 32,160
Repayments of related party advances (2,850)
Net cash provided by financing activities 103,599 49,310
Net increase (decrease) in cash 39,824 (304)
Cash at beginning of period 1,084 1,388
Cash at end of period 40,908 1,084
Supplemental disclosure of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash financing activities:    
Non-cash exercise of stock options 49,467
Forgiveness of shareholder loans 526,888
Conversion of notes payable to common stock 17,958
Conversion of shareholder loans to common stock $ 94,135